Delta-like non-canonical Notch ligand 1 (DLK1) - a novel biomarker in adrenocortical carcinoma
James Pittaway(Queen Mary University of London), Leonardo Guasti(Queen Mary University of London), Martin Faßnacht(University of Würzburg), Tarek Abdel-Azziz, Cristina L. Ronchi(University of Birmingham), Barbara Altieri(Universitätsklinikum Würzburg), Matthias Kroiß, Laura-Sophie Landwehr, Katia Mariniello(Queen Mary University of London), Scott Akker, Teng‐Teng Chung(University College Hospital), Fausto Palazzo(Hammersmith Hospital), Laila Parvanta(St Bartholomew's Hospital), Silviu Sbiera(University of Würzburg), Aimee N. Di Marco(Imperial College Healthcare NHS Trust), William Drake, Iuliu Sbiera
Cited by 0
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2018|927
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766